Home
Choose language  
Pharmacoreport Pharmacoreport
www.pharmacoreport .com is a news site providing information about the top international pharmaceutical companies. This website will also provide other information about these pharmaceuticals like their address and locations, corporate history, clinical trials, annual report, employees, careers and jobs, health care products, research, sales, shares, dividend & stock price, and patients’ assistance program.
 
Merck KGaA   Merck

 


Established in the year 1668 by Friedrich Jacob Merck, Merck KGaA is the Germany based pharmaceutical company having it’s headquarter situated at Darmstadt in Germany. Merck KGaA is also popularly known as German Merck or Merck Darmstadt. It is one of the oldest and still operationally going strong chemical and pharmaceutical enterprises across the world today. The company was privately owned until 1995 when it went public duly incorporated. The Merck family still has the majority of the company’s shares under their control empowering them to manage the corporate company.

 

Immediately after the WW-I episode, Merck lost their possession on their foreign units which included the Merck & Co – the company’s subsidiary located in the United States as well as Merck & Co known as Merck Sharp and Dome – MSD outside the United States and Canada which is currently an independent entity. Merck KGaA is supposed to operate chiefly in the member countries of the European Union. 

 

The history of Merck is believed to be very interesting like the company’s roots dates back to the 17th century. During the year 1668, an archaic dispensing chemist named Friedrich Jacob Merck took-over the possession of the Engel-Apotheke or say Engel Pharmacy in Darmstadt in Germany.

 

Many recognized and successful products have been invented by Merck but currently the main concentration of the pharmaceutical R&D is on Oncology and Cardio-metabolic Care. In the earlier therapeutic segments, the company’s first sold product is Erbitux having Cetuximab for which the company has world-wide marketing rights except North America where it is sold by Bristol-Myers Squibb.   

 

The other major products of the company include: Metformin, Bisoprolol and Digitoxin.


Teisho Pharmaceutical , Shienogi and Co , Akzo Nobal , Hofmann_La Roche , Elcon , H Lundback , Nowo Nordisk , Eishai Co , AstraZeneka , Sanophi Aventis
Latest News About merck kgaa
The new face of Merck KgaA. (Business Roundup)
$9.95
Merck KGaA’s ethical business has, to date, was been based on its diabetes and... Merck KGaA’s the largest advantage its RandD piping that contained is,....More
Merck KGaA& Erbitux phase III trial for cancer shows improved...
Forbes
Merck KGaA plans to issue Euro general reference point connection... - Color

Color - 1, 2007 Damages
FRANKFURT (AFX) - Merck (nyse: MRK - messages - of people) KGaA sees SOWED synergies of its union with Serono (nyse: SRA - messages - of people) of 200 mln Eurs through 2009,....More
Merck KGaA upbeat on year NEWS DIGEST.(COMPANIES & FINANCE...
Free with regis
FRANKFURT (AFX) - its control cut Merck KgaA for revenue in the present year when it revealed a 22.6 pct slump in third quarter EBIT to 214.7 mln Eurs of 277.4....More
Merck KGaA confirms 77 eur per share all-cash offer for Schering
Forbes
Merck KGaA confirms 77 Eurs per share all-cash.. - Color

Color - Damages 23, 2006>>
DARMSTADT, Germany (AFX) - Merck KGaA plans to sell Schering AGand diagnosis businesses if the acceptance of the firm, industries source succeeds....More
Merck KGaA on right track for reaching 1 bln eur annual sales in...
Forbes
Merck climbs KGaA Q1 opg 11.4 pct to 321.3 mln Eurs - Color

Color - On the 18th Jan, 2007
FRANKFURT (AFX) - Merck KGaA said that its fourth quarter operating profit to 303.3 mln Eurs of 191.7 mln Eurs climbed, on 58.2 pct of the same period a year....More
MERCK KGaA
$1,440.00 - ESPICOM BU
On 23 March 2000 Merck KGaA announced that its USA Lizenznehmer for Glucophage... the agreement, will furnish Merck KGaA $480000 to underpin research in,....More
SMITHKLINE BEECHAM, HUMAN GENOME SCIENCES, AND MERCK KGAA SIGN...
Subscription
DARMSTADT, Germany (AFX) - Merck KGaA said that it decided to interrupt development its Parkinsonand drug Sarizotan after analysis of phase III data,....More
Merck KGaA keen to co-operate with Schering winner Bayer UPDATE
Forbes
German stockholders protection groups seek poet... - Color

Color - Dec 16, 2004
DARMSTADT, Germany (AFX) - Merck KGaA said that it will attain Schott AGand Lumitec OLED research and development project for igniting devices prototype,....More
Schering employees support co against Merck KGaA takeover
Forbes
AP. FRANKFURT, Germany: German drugmaker Merck KGaA said Thursday that its quarter quarter profit 18 climbed percent after the firm, has revenue its Erbitux gefördert...More
Merck KgaA says Parkinson drug safinamide trial unsuccessful; further...
Forbes
FRANKFURT (AFX) - German Lufthansa AGand leader of the finance department Karl-Ludwig Kley the firm does not leave specified for one position at on Darmstadt basiert...More